Developer docs
API playgroundTry for free, no card

Search company profiles

Strainprint Technologies

Full company profile

uuid00042az

Namestring
Strainprint Technologies
Legal namestring
Strainprint Technologies Ltd.
Websiteurl
strainprint.ca
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Strainprint Technologies Ltd. is a Toronto-based cannabis data and analytics company founded in 2016. Its core offering is a patient-facing mobile app (iOS and Android) that enables medical cannabis users to log sessions — capturing symptom, strain, ingestion method, and dosage — and earn loyalty rewards through the Strainpoints program. Aggregated, anonymized session data feeds a proprietary real-world evidence library covering more than 800,000 patient outcomes across 100+ symptoms and hundreds of cannabis strains, stored in Canada under HIPAA, PIPEDA and PHIPA compliant infrastructure.

The company monetizes this dataset primarily through an enterprise analytics platform sold on annual subscriptions to licensed producers, cannabis retailers, healthcare clinics, and government stakeholders (Health Canada is a named partner). A subscription research product, Strainprint Reports, provides analyst reports and custom research for medical cannabis practitioners and product formulators, while a white-label/OEM track has produced the myTrek app deployed with Australian partner Cannatrek. Customer logos include Aurora Cannabis, Tilray, Tikun Olam, WeedMD, 48North, MÜV, LYTE Clinics, GrowWise Health, VerdePharmHealth, and Bayer, with Surterra Wellness representing its first U.S. account.

The company was self-funded by a USD $3 million Series A in May 2018 led by Cesare Fazari of Molecular Science Corp and has not disclosed subsequent priced financing. Leadership comprises founder Stephanie Karasick, CEO Andrew Muroff, and President/CTO David Berg, with a medical advisory board that includes Drs. Caroline MacCallum, Danial Schecter, and Dean Elterman. The company operates from Toronto, Canada, with a headcount in the 11–50 range.

Short descriptiontext

Strainprint Technologies is a Toronto-based cannabis data and analytics company that runs a patient mobile app for tracking medical cannabis sessions and sells enterprise analytics, research reports, and white-label deployments to licensed producers, clinics, and government health authorities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cannabis patient tracking, medical cannabis analytics, real-world evidence platform, cannabis data analytics, patient outcomes research
Industry1 code
PRIMARYCRANAGAF
Third-Party White-Label Ordering & Delivery Platforms (SaaS + Logistics)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Delivery & Online Ordering Retail
NAICS code1 code
  • Testing Laboratories and Services54138
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Medical Cannabis Data & Analytics
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Enterprise Analytics Subscriptions
TypeSubscription Recurring
Description

Subscription-based analytics platform licenses to licensed producers, retailers, and healthcare clinics for access to real-time patient data, treatment efficacy insights, and industry benchmarking.

strainprint.ca
2Research Reports
TypeSubscription Recurring
Description

Sale of comprehensive research reports and custom research to medical cannabis practitioners, product formulators, and industry stakeholders seeking evidence-based insights.

strainprint.ca
3Patient App (Freemium)
TypeFreemium
Description

Free mobile application for patients with loyalty rewards (Strainpoints) earned through session tracking, driving data collection while monetizing through enterprise subscriber access to aggregated insights.

strainprint.ca
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details2 tiers
1Free patient app with loyalty rewards
ModelFreemiumBilling cadenceMonthly
Notes

Free download and tracking for patients; earn Strainpoints loyalty rewards for tracked sessions redeemable for swag and discounts.

strainprint.ca
2Enterprise Analytics Platform
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing for licensed producers, retailers, and healthcare clinics requiring full dataset access and analytics.

strainprint.ca
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Core offering1 text field

Strainprint operates a patient-facing mobile cannabis tracking application (iOS/Android) that lets medical cannabis patients log sessions, symptoms, strains, ingestion methods and dosages to optimize treatment, paired with a subscription analytics platform that sells aggregated, anonymized real-world patient outcomes data, research study monitoring, and custom research reports to licensed cannabis producers, retailers, healthcare clinics, and researchers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 47.3% reduction in headache severity reported in WSU study using Strainprint data
+3 more records
Product overview1 text field

Strainprint Technologies operates as a unified platform-plus-modules architecture, anchored by the Strainprint Mobile App for patient-side session tracking and the Strainprint Analytics platform for enterprise data access. The product portfolio extends through the Strainprint Reports subscription service, the Strainprint Community online forum, the Strainpoints™ loyalty program, and StrainSheets® educational content. A white-label variant (myTrek App) is distributed through the Cannatrek partnership. The core value proposition ties patient tracking data into aggregated analytics that feed reports and research insights, with loyalty rewards incentivizing sustained data contribution.

Product and service4 records
1Strainprint Mobile App
CategoryMobile cannabis tracking app (consumer)
Description

Patient-facing mobile cannabis tracking application (iOS/Android) that allows medical cannabis patients to log sessions, symptoms, strains, ingestion methods, and dosages, view efficacy history, and earn Strainpoints loyalty rewards for data contribution.

2Strainprint Analytics
CategoryEnterprise analytics platform (B2B)
Description

Subscription-based business intelligence and analytics platform that provides subscribers with real-time patient usage data, treatment efficacy analysis, industry trend monitoring, and research study performance dashboards. Sold to licensed cannabis producers, retailers, and healthcare clinics on annual enterprise subscriptions.

3Strainprint Reports
CategorySubscription research reports
Description

Subscription and custom research report product offering comprehensive analyst reports on Canadian medical cannabis experience, polypharmacy trends, and bespoke research for medical cannabis practitioners, product formulators, and industry stakeholders.

4myTrek App (White-label OEM)
CategoryWhite-label / OEM product
Description

White-label version of Strainprint tracking technology deployed exclusively for Cannatrek patients to monitor health and safety and deliver personalized treatment recommendations.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2023-04-26
Description

Aurora Cannabis partnered with Strainprint in April 2023 to launch a new tracking program designed to support and empower cannabis patients on their wellness journey. The partnership enables Aurora to offer Strainprint's tracking capabilities to their patient base.

2Tilray Medical
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-08-25
Description

Tilray Medical partnered with Strainprint for the CannaPoints program supporting medical cannabis patients across Canada. Integration provides tracking capabilities alongside Tilray's product offerings.

strainprint.ca
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2019-05-07
Description

Strategic working relationship to integrate Strainprint's patient data with TruTrace's StrainSecure traceability platform. Companies entered LOI for joint venture to develop tools improving cannabis patient experience through combined data and traceability.

Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing Partner
Description

Exclusive partnership to launch myTrek tracking app for Cannatrek patients. The app helps Cannatrek monitor customer health and safety and deliver treatment recommendations, enabling more confident production of suitable strains.

5VerdePharmHealth
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to provide technology supporting transformation of physician practices toward improved decision-support for medical cannabis interventions, coupled with patient-reported outcomes. Aimed at serving patients nationwide.

strainprint.ca
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

International clinical trial partnership to establish world's first and largest database of medical cannabis effects on women. Partnership with Gynica and Lumir Lab focuses on treating endometriosis symptoms.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Clinical trial partnership for monitoring real-time cannabis treatment for endometriosis symptoms. Leverages Strainprint's comprehensive research platform.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

First U.S. customer to Strainprint's comprehensive cannabis intelligence platform. Surterra gained access to Strainprint's data and analytics capabilities for their U.S. patient base.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

WeedMD subscribed to Strainprint's data and analytics platform to gain key insights into consumer preferences for developing optimal cannabis products.

Strategic tierMinorTypeOthers
Description

Affiliation with MaRs, an organization helping companies bring breakthrough ideas to market and scale globally.

11Global Cannabis Partnership
Strategic tierMinorTypeOthers
Description

Active member of the Global Cannabis Partnership, a collaboration of leaders in government-sanctioned adult-use recreational cannabis industry adhering to Responsible Cannabis Framework.

strainprint.ca
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Global cannabis pioneer gained access to broad spectrum of Strainprint's product suite for medical cannabis treatment support and product optimization.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

BDSA is a cannabis market intelligence and data analytics firm producing syndicated research, consumer insights, and sales tracking for the global cannabis industry. It directly competes with Strainprint Reports and analytics subscriptions targeting the same LP, CPG, and investor customer base.

TypeBroad incumbent
Description

Leafly is the largest cannabis strain and product discovery platform with deep consumer engagement data and a B2B advertising/data arm. It is a broader incumbent in cannabis data and strain information, with overlapping use cases to Strainprint's symptom-strain matching and product database.

TypeEmerging player
Description

Springbig is a cannabis loyalty, CRM, and marketing automation platform used by dispensaries and brands. It is an emerging SaaS peer in the cannabis retail/patient engagement space, overlapping with Strainprint's patient tracking and Strainpoints loyalty features.

TypeBroad incumbent
Description

Weedmaps is a leading cannabis marketplace and SaaS provider (WM Technology) with retailer, brand, and consumer data assets. As a broader incumbent, it competes for the same enterprise wallet and offers adjacent data products to Strainprint's analytics.

5Cannvas MedTech
TypeRegional player
Description

Cannvas MedTech is a Canadian cannabis education and data company offering a patient-facing platform with health assessment and learning tools. It is a regional peer operating in the same Canadian medical cannabis market with overlapping patient education and data themes.

6Headset
TypeDirect peer
Description

Headset is a cannabis retail and consumer data analytics platform serving dispensaries, brands, and distributors with point-of-sale integrations and market intelligence. It is the closest direct peer to Strainprint's enterprise analytics offering, though it is more retail/point-of-sale focused whereas Strainprint is patient-outcome focused.

TypeDirect peer
Description

New Frontier Data provides cannabis industry data, market sizing, and consumer research reports, including the Cannabis Industry Annual Report. It competes with Strainprint Reports for the same enterprise insights buyers.

TypeEmerging player
Description

Jointly is a cannabis wellness app that helps consumers track sessions, set intentions, and match products to effects. It is an emerging player in cannabis consumer tracking with significant overlap to Strainprint's patient app and data collection.

9Akerna (acquired by Acuant, now Navigategate)
TypeBroad incumbent
Description

Akerna (formerly MJ Freeway) provides cannabis seed-to-sale compliance, ERP, and analytics software to operators and regulators. It is a broader incumbent in cannabis enterprise software and data, competing for a portion of Strainprint's analytics budget.

10Cannametrics
TypeEmerging player
Description

Cannametrics provides cannabis consumer and market analytics for retailers, brands, and LPs with panel-based insights and point-of-sale integrations. It is an emerging analytics peer competing for a portion of Strainprint's enterprise intelligence and reports business.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Strainprint Technologies

Medical Cannabis Data & Analyticsstrainprint.ca

Strainprint Technologies is a Toronto-based cannabis data and analytics company that runs a patient mobile app for tracking medical cannabis sessions and sells enterprise analytics, research reports, and white-label deployments to licensed producers, clinics, and government health authorities.

What Strainprint Technologies does

Strainprint Technologies Ltd. is a Toronto-based cannabis data and analytics company founded in 2016. Its core offering is a patient-facing mobile app (iOS and Android) that enables medical cannabis users to log sessions — capturing symptom, strain, ingestion method, and dosage — and earn loyalty rewards through the Strainpoints program. Aggregated, anonymized session data feeds a proprietary real-world evidence library covering more than 800,000 patient outcomes across 100+ symptoms and hundreds of cannabis strains, stored in Canada under HIPAA, PIPEDA and PHIPA compliant infrastructure.

The company monetizes this dataset primarily through an enterprise analytics platform sold on annual subscriptions to licensed producers, cannabis retailers, healthcare clinics, and government stakeholders (Health Canada is a named partner). A subscription research product, Strainprint Reports, provides analyst reports and custom research for medical cannabis practitioners and product formulators, while a white-label/OEM track has produced the myTrek app deployed with Australian partner Cannatrek. Customer logos include Aurora Cannabis, Tilray, Tikun Olam, WeedMD, 48North, MÜV, LYTE Clinics, GrowWise Health, VerdePharmHealth, and Bayer, with Surterra Wellness representing its first U.S. account.

The company was self-funded by a USD $3 million Series A in May 2018 led by Cesare Fazari of Molecular Science Corp and has not disclosed subsequent priced financing. Leadership comprises founder Stephanie Karasick, CEO Andrew Muroff, and President/CTO David Berg, with a medical advisory board that includes Drs. Caroline MacCallum, Danial Schecter, and Dean Elterman. The company operates from Toronto, Canada, with a headcount in the 11–50 range.

Strainprint Technologies firmographics

Firmographics
Name
Strainprint Technologies
Legal name
Strainprint Technologies Ltd.
Website
https://strainprint.ca
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Strainprint Technologies is a Toronto-based cannabis data and analytics company that runs a patient mobile app for tracking medical cannabis sessions and sells enterprise analytics, research reports, and white-label deployments to licensed producers, clinics, and government health authorities.
Ownership category
akta.pro rank

Strainprint Technologies industry classification

Industry
Product category
Medical Cannabis Data & Analytics
NAICS
Testing Laboratories and Services (54138)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYCRANAGAF
Third-Party White-Label Ordering & Delivery Platforms (SaaS + Logistics)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Delivery & Online Ordering Retail

Keywords

  • Cannabis patient tracking
  • Medical cannabis analytics
  • Real-world evidence platform
  • Cannabis data analytics
  • Patient outcomes research

Where Strainprint Technologies is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

Strainprint Technologies business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Enterprise Analytics Subscriptions: Subscription-based analytics platform licenses to licensed producers, retailers, and healthcare clinics for access to real-time patient data, treatment efficacy insights, and industry benchmarking.
  2. Research Reports: Sale of comprehensive research reports and custom research to medical cannabis practitioners, product formulators, and industry stakeholders seeking evidence-based insights.
  3. Patient App (Freemium): Free mobile application for patients with loyalty rewards (Strainpoints) earned through session tracking, driving data collection while monetizing through enterprise subscriber access to aggregated insights.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyFree patient app with loyalty rewards
SubscriptionAnnualEnterprise Analytics Platform

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Strainprint Technologies product offering

Product offering

Core offering

Strainprint operates a patient-facing mobile cannabis tracking application (iOS/Android) that lets medical cannabis patients log sessions, symptoms, strains, ingestion methods and dosages to optimize treatment, paired with a subscription analytics platform that sells aggregated, anonymized real-world patient outcomes data, research study monitoring, and custom research reports to licensed cannabis producers, retailers, healthcare clinics, and researchers.

Product overview

Strainprint Technologies operates as a unified platform-plus-modules architecture, anchored by the Strainprint Mobile App for patient-side session tracking and the Strainprint Analytics platform for enterprise data access. The product portfolio extends through the Strainprint Reports subscription service, the Strainprint Community online forum, the Strainpoints™ loyalty program, and StrainSheets® educational content. A white-label variant (myTrek App) is distributed through the Cannatrek partnership. The core value proposition ties patient tracking data into aggregated analytics that feed reports and research insights, with loyalty rewards incentivizing sustained data contribution.

Differentiator

Problem solved

Functional benefit

Products and services

  • Strainprint Mobile App Patient-facing mobile cannabis tracking application (iOS/Android) that allows medical cannabis patients to log sessions, symptoms, strains, ingestion methods, and dosages, view efficacy history, and earn Strainpoints loyalty rewards for data contribution.
  • Strainprint Analytics Subscription-based business intelligence and analytics platform that provides subscribers with real-time patient usage data, treatment efficacy analysis, industry trend monitoring, and research study performance dashboards. Sold to licensed cannabis producers, retailers, and healthcare clinics on annual enterprise subscriptions.
  • Strainprint Reports Subscription and custom research report product offering comprehensive analyst reports on Canadian medical cannabis experience, polypharmacy trends, and bespoke research for medical cannabis practitioners, product formulators, and industry stakeholders.
  • myTrek App (White-label OEM) White-label version of Strainprint tracking technology deployed exclusively for Cannatrek patients to monitor health and safety and deliver personalized treatment recommendations.

Quantifiable outcome

  • 47.3% reduction in headache severity reported in WSU study using Strainprint data
  • +3 more outcomes

Companies that use Strainprint Technologies

Customer profile

Named customers12 records

Segments4 records

Ideal customer profiles4 records

Strainprint Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Strainprint Technologies partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered flagship, core, strategic and minor.

  • Aurora CannabisflagshipStrategic or Co-development Partner · 26 April 2023Aurora Cannabis partnered with Strainprint in April 2023 to launch a new tracking program designed to support and empower cannabis patients on their wellness journey. The partnership enables Aurora to offer Strainprint's tracking capabilities to their patient base.
  • Tilray MedicalcoreStrategic or Co-development Partner · 25 August 2022Tilray Medical partnered with Strainprint for the CannaPoints program supporting medical cannabis patients across Canada. Integration provides tracking capabilities alongside Tilray's product offerings.
  • TruTrace TechnologiescoreTechnology or Integration · 7 May 2019Strategic working relationship to integrate Strainprint's patient data with TruTrace's StrainSecure traceability platform. Companies entered LOI for joint venture to develop tools improving cannabis patient experience through combined data and traceability.
  • CannatrekflagshipOEM/ Whitelabel/ Licensing PartnerExclusive partnership to launch myTrek tracking app for Cannatrek patients. The app helps Cannatrek monitor customer health and safety and deliver treatment recommendations, enabling more confident production of suitable strains.
  • VerdePharmHealthcoreStrategic or Co-development PartnerPartnership to provide technology supporting transformation of physician practices toward improved decision-support for medical cannabis interventions, coupled with patient-reported outcomes. Aimed at serving patients nationwide.
  • GynicastrategicStrategic or Co-development PartnerInternational clinical trial partnership to establish world's first and largest database of medical cannabis effects on women. Partnership with Gynica and Lumir Lab focuses on treating endometriosis symptoms.
  • Lumir LabstrategicStrategic or Co-development PartnerClinical trial partnership for monitoring real-time cannabis treatment for endometriosis symptoms. Leverages Strainprint's comprehensive research platform.
  • Surterra WellnesscoreStrategic or Co-development PartnerFirst U.S. customer to Strainprint's comprehensive cannabis intelligence platform. Surterra gained access to Strainprint's data and analytics capabilities for their U.S. patient base.
  • WeedMDcoreStrategic or Co-development PartnerWeedMD subscribed to Strainprint's data and analytics platform to gain key insights into consumer preferences for developing optimal cannabis products.
  • MaRsminorOthersAffiliation with MaRs, an organization helping companies bring breakthrough ideas to market and scale globally.
  • Global Cannabis PartnershipminorOthersActive member of the Global Cannabis Partnership, a collaboration of leaders in government-sanctioned adult-use recreational cannabis industry adhering to Responsible Cannabis Framework.
  • Tikun OlamcoreStrategic or Co-development PartnerGlobal cannabis pioneer gained access to broad spectrum of Strainprint's product suite for medical cannabis treatment support and product optimization.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Strainprint Technologies competitors and assessment

Company assessment

Direct peers

  • BDSA (formerly BDS Analytics): BDSA is a cannabis market intelligence and data analytics firm producing syndicated research, consumer insights, and sales tracking for the global cannabis industry. It directly competes with Strainprint Reports and analytics subscriptions targeting the same LP, CPG, and investor customer base.
  • Headset: Headset is a cannabis retail and consumer data analytics platform serving dispensaries, brands, and distributors with point-of-sale integrations and market intelligence. It is the closest direct peer to Strainprint's enterprise analytics offering, though it is more retail/point-of-sale focused whereas Strainprint is patient-outcome focused.
  • New Frontier Data: New Frontier Data provides cannabis industry data, market sizing, and consumer research reports, including the Cannabis Industry Annual Report. It competes with Strainprint Reports for the same enterprise insights buyers.

Broad incumbents

  • Leafly: Leafly is the largest cannabis strain and product discovery platform with deep consumer engagement data and a B2B advertising/data arm. It is a broader incumbent in cannabis data and strain information, with overlapping use cases to Strainprint's symptom-strain matching and product database.
  • Weedmaps: Weedmaps is a leading cannabis marketplace and SaaS provider (WM Technology) with retailer, brand, and consumer data assets. As a broader incumbent, it competes for the same enterprise wallet and offers adjacent data products to Strainprint's analytics.
  • Akerna (acquired by Acuant, now Navigategate): Akerna (formerly MJ Freeway) provides cannabis seed-to-sale compliance, ERP, and analytics software to operators and regulators. It is a broader incumbent in cannabis enterprise software and data, competing for a portion of Strainprint's analytics budget.

Emerging players

  • Springbig: Springbig is a cannabis loyalty, CRM, and marketing automation platform used by dispensaries and brands. It is an emerging SaaS peer in the cannabis retail/patient engagement space, overlapping with Strainprint's patient tracking and Strainpoints loyalty features.
  • Jointly: Jointly is a cannabis wellness app that helps consumers track sessions, set intentions, and match products to effects. It is an emerging player in cannabis consumer tracking with significant overlap to Strainprint's patient app and data collection.
  • Cannametrics: Cannametrics provides cannabis consumer and market analytics for retailers, brands, and LPs with panel-based insights and point-of-sale integrations. It is an emerging analytics peer competing for a portion of Strainprint's enterprise intelligence and reports business.

Regional players

  • Cannvas MedTech: Cannvas MedTech is a Canadian cannabis education and data company offering a patient-facing platform with health assessment and learning tools. It is a regional peer operating in the same Canadian medical cannabis market with overlapping patient education and data themes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Strainprint Technologies social profiles

Digital presence

Strainprint Technologies compliance and trust

Trust signal

Compliance3 records

Strainprint Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Strainprint Technologies leadership team

Management profile

Number of profiles

Profiles12 records

Strainprint Technologies funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Strainprint Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Strainprint Technologies

What does Strainprint Technologies do?

Strainprint operates a patient-facing mobile cannabis tracking application (iOS/Android) that lets medical cannabis patients log sessions, symptoms, strains, ingestion methods and dosages to optimize treatment, paired with a subscription analytics platform that sells aggregated, anonymized real-world patient outcomes data, research study monitoring, and custom research reports to licensed cannabis producers, retailers, healthcare clinics, and researchers.

Is Strainprint Technologies a public or private company?

Strainprint Technologies is a private company. It is classified as venture growth investor backed and is currently operating.

When was Strainprint Technologies founded?

Strainprint Technologies was founded in 2016. It employs 1 to 10 people.

Where is Strainprint Technologies based?

Strainprint Technologies is headquartered in Toronto, Canada, in the North America region.

How does Strainprint Technologies make money?

Three revenue lines are on record. Enterprise Analytics Subscriptions are the primary driver. The others are research Reports and patient App (Freemium).

Who are Strainprint Technologies's main competitors?

Direct peers on record are BDSA (formerly BDS Analytics), Headset and New Frontier Data. Broad incumbents are Leafly, Weedmaps and Akerna (acquired by Acuant, now Navigategate). Emerging players are Springbig, Jointly and Cannametrics. Cannvas MedTech is listed as a regional player.

Does Strainprint Technologies have an API?

No public API is recorded for Strainprint Technologies.

What industry is Strainprint Technologies in?

Strainprint Technologies's product category is Medical Cannabis Data & Analytics. Its primary akta.pro industry code is CRANAGAF, Third-Party White-Label Ordering & Delivery Platforms (SaaS + Logistics). Its NAICS code is 54138 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
UtahcannaCannabis Tech Startups Revolutionizing Patient CareInnovation in the medical cannabis industry is driven by technology, with startups introducing data-driven care and personalized treatment solutions. Platforms like Strainprint and Releaf App are allowing patients to track symptoms and adjust dosages in real time, while telehealth services like NuggMD and Veriheal enhance access to cannabis care. The integration of AI and blockchain technology is anticipated to transform patient outcomes and secure medical records, despite challenges such as regulatory compliance and digital accessibility.PR NewswireStrainprint® Technologies Ltd. Launches the First Medical Cannabis Industry Report Based on the Largest Real-World Observational Patient StudyStrainprint Technologies Ltd. released The Canadian Medical Cannabis Experience: A 2019 Patient Retrospective, analyzing over 800,000 real-time anonymous patient outcomes from medical cannabis use in Canada during 2018. The report is the largest real-world observational patient study in the medical cannabis industry, identifying key findings including the top five symptoms treated (muscle pain, anxiety, depression, joint pain, insomnia), gender and regional differences in administration methods, and the role of terpene profiles in efficacy. The findings showed patients overwhelmingly report positive or neutral emotive effects with few unfavorable side effects, and no significant change in treatment patterns after recreational cannabis legalization in Canada.PR NewswireStrainprint™ Technologies Ltd. And Gynica launch Next Phase of Cannabis Study to Treat Endometriosis SymptomsStrainprint Technologies Ltd. and Gynica announced the next phase of their joint clinical trial to study cannabis as a treatment for endometriosis, launching a custom questionnaire to recruit eligible participants in Canada and Israel. The study, described as the world's first international clinical research on cannabis use for endometriosis, will leverage Strainprint's patient-reported outcomes database alongside questionnaire results to develop a cannabis-based product formulation. Participants from both countries who complete the questionnaire will subsequently be invited to join the clinical trial of the resulting therapy.PR NewswireStrainprint™ Technologies Welcomes U.S. Subscriber with Cannabis Operations in Four StatesStrainprint Technologies Ltd, a Toronto-based cannabis data and analytics company, announced that Calyx Peak Companies has become a new subscriber to its analytics platform. Calyx Peak, a multi-state cannabis operator managing 27 permits across California, Ohio, Nevada, and Massachusetts with approximately 300,000 square feet of cultivation facilities, will use Strainprint's data to optimize product development and monitor customer treatment outcomes. The platform contains over 1.3 million anonymized patient-reported medical cannabis outcomes and more than 65 million data points on strain efficacy.PR NewswireStrainprint™ Technologies Launches New Research Reports Product LineStrainprint Technologies Ltd. has launched Strainprint Reports, a new product line of evidence-based research reports leveraging its proprietary patient-reported outcomes data from the cannabis industry. The initial offerings include specific studies on insomnia and polypharmacy, with plans to release a comprehensive Canadian Medical Cannabis Report based on over 800,000 patient outcomes.PR NewswireStrainprint™ Technologies Welcomes Surterra Wellness as First U.S. Customer to its Comprehensive Cannabis Intelligence PlatformStrainprint Technologies Ltd announced its expansion into the U.S. cannabis market with Surterra Wellness as its first U.S. customer. Surterra Wellness will leverage Strainprint's full suite of data analytics, including a branded mobile app for tracking medical cannabis treatment sessions and access to the Strainprint Analytics web platform containing data from over 950,000 anonymized medical outcomes. The partnership marks Strainprint's entry into the U.S. market following its operations in Canada since 2016.PR NewswireStrainprint™ Technologies, Lumir Lab and Gynica Announce Clinical Trial Partnership Establishing World's First and Largest Database of Medical Cannabis Effects on WomenStrainprint Technologies Ltd. announced a partnership with Israeli research organizations Lumir Lab and Gynica to conduct the world's first international clinical study on medical cannabis treatment for endometriosis, with simultaneous studies planned in Israel and Canada. The study will leverage Strainprint's database of over 900,000 patient outcomes and 40 million data points to identify which cannabinoid combinations provide the most effective relief for endometriosis symptoms. The three organizations expect the clinical trial to launch in Q2 2019, with a goal of recruiting up to 1,000 patients in each country to develop clinically-validated cannabinoid-based products for international distribution.PR NewswireStrainprint™ Technologies Ltd. Launches the Strainprint Community - an Online Forum Providing Cannabis Education and Resources to Coincide With Legalization in CanadaStrainprint Technologies Ltd., a Toronto-based cannabis data and analytics company, has launched the Strainprint Community, an online forum providing education, discussion forums, and support resources for cannabis users in Canada. The platform was created to help both medical patients and recreational users navigate Canada's transition to legalized cannabis. With over 800,000 anonymous health records and 30 million data points, Strainprint Analytics is described as the leading source of medical cannabis data in North America.GlobeNewswireUPDATE: NexTech to Broadcast First Ever Cannabis Augmented Reality Live Streaming Event in Partnership With CFN Media and StrainprintNexTech will broadcast its first cannabis augmented reality live streaming event at the New West Summit in Oakland, CA, on October 11th, featuring Strainprint founder Stephanie Karasick as a hologram. The event will stream from Toronto to the summit and worldwide via the Aritize app, with CFN Media marketing the technology to cannabis clients.NewswireMedia Advisory - Strainprint™ Technologies Ltd. to Launch the Strainprint Community - A Tool to Help Cultivate Positive Social Awareness, Education & Support for Canadians Pre and Post Cannabis LegalizationStrainprint Technologies Ltd. will launch the Strainprint Community, an online space for cannabis education and support, on Oct. 16, 2018, in Toronto. The company plans to use its existing cannabis data and analytics to provide resources for responsible use. The launch is an invite-only media luncheon.